CROs/Service Providers

INC Research launches Vaccine Catalyst Site Network

Thursday, July 28, 2016

INC Research Holdings, a, global phase I to IV CRO, has launched the company’s Vaccine Catalyst Site network as part of its Catalyst program introduced earlier this year to strengthen collaborations with clinical research sites worldwide, ultimately enhancing patient focus and optimizing study delivery to drive improved predictability and increased efficiency for customers. INC selected 40 high-performing clinical research sites to participate in the initial launch of its Vaccine Catalyst Site network, which was formed to respond to the rapid growth and strong pipeline of vaccine studies.

[Read More]

Veristat continues expansion in North Carolina

Friday, July 1, 2016

Veristat, a full service CRO with over 20 years of experience, is continuing its accelerated growth and geographic expansion with the opening of an office in Raleigh-Durham, North Carolina. In addition to this newly planned North Carolina office, Veristat has additional North American-based offices in Southborough, Massachusetts, Cambridge, Massachusetts, San Bruno, California, Montreal, Canada, and its European office in Glasgow, U.K.

[Read More]

ICON to acquire Clinical Research Management

Thursday, June 30, 2016

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to acquire Clinical Research Management (ClinicalRM). The acquisition will enhance Icon’s ability to access the market for government sponsored research and further enhances Icon’s capabilities in the areas of Vaccines and Infectious Disease.

[Read More]

DrugDev launches CRO Preferred Partner Program

Tuesday, June 28, 2016

For years, DrugDev technology has been used directly by leading pharmaceutical companies to improve how their clinical trials are run. In order to advance collaboration and standardization that drive benefits throughout the industry and enable companies to do more trials, the company has launched its CRO Preferred Partner program alongside Charter Member INC Research.

[Read More]

Biomedical Systems opens Technology and Research Center

Tuesday, June 28, 2016

Biomedical Systems, a 40-year-old family-owned clinical trial provider to pharmaceutical, medical device, biotech and CROs, has opened its new Technology and Research Center in St. Louis, near the company’s global headquarters. The state-of-the-art 12,000-square-foot center houses more than 70 software developers, data technicians and business analysts. The center was designed to foster innovation and integration of new technology, in collaboration with customers, to improve efficiencies and ultimately help expedite pharmaceuticals and devices to patients.  

[Read More]